Breast Cancer, Botticelli (Umberto I): "With Genomic Tests -40% Chemotherapy Prescriptions"
7 Articles
7 Articles
The genomic tests allow us to know the mutations at the level of the genes, and in breast cancer these become particularly important because they allow us to define the risk of relapse, that is to say of recurrence of the disease. The introduction of genomic tests has allowed us to reduce the prescriptions of chemotherapy by at least 40%. [...]
(Adnkronos) - "Genomic tests allow us to know the mutations at the level of the genes, and in breast cancer these become particularly important because they allow us to define the risk of relapse, that is...
The genomic tests allow us to know the mutations at the level of the genes, and in the breast cancer these become particularly important because there
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium




